Kazia Therapeutics Soars 11.45% on Reverse Split

On July 8, 2025, Kazia Therapeutics' stock surged by 11.45% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Kazia Therapeutics has been the subject of various forecasts and price targets. Analysts have predicted that the stock could rise by 80.57% over the next three months, with a 90% probability of holding a price between $9.99 and higher. Additionally, the average twelve-month price target for the stock is $57.50, with some analysts setting a high target of $100.00.

Recent corporate actions have also impacted the stock. Kazia Therapeutics recently performed a 1 for 5 reverse split, which means shareholders now hold 1 share for every 5 they previously owned. This action is often taken to increase the stock price and attract more investors.